Additionally, low levels of circulating Gal-9 or PD-L1 were significantly associated with poor survival in 81 patients with hepatocellular carcinoma analyzed via enzyme-linked immunosorbent assay. The gene discussed is LGALS9; the disease is hepatocellular carcinoma.